Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.
PRICE
Prev Close
9.60
Open
9.49
Day Range8.22 – 10.69
8.22
10.69
52W Range3.82 – 20.99
3.82
20.99
29% of range
50-Day MA
6.35(+39.1%)
200-Day MA
8.84(-0.2%)
VOLUME & SIZE
Avg Volume
58.8K
FUNDAMENTALS
P/E Ratio
-0.2x
Not profitable
EPS (TTM)
—
Div Yield
No dividend
Beta
1.34
Market-like
TECHNICAL
RSI (14)
64
Bullish momentum
RNAZ News
About
transcode therapeutics is a boston based pre-clinical biopharmaceutical company focused on discovery, development and commercialization of a pipeline of innovative microrna (mirnas or mirs) therapeutics for treating metastatic disease.